AUNA · Auna S.A. · Investor Relations
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-07-20 |
Auna Announces Reporting Dates for Second Quarter 2026 Financial Results
Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2026 financial results. Earnings Release Tuesday, August 18, 2026 Time: After Market Close Conference Call Wednesday, August 19, 2026 Time: 8:00 a.m. ET Quiet Period Monday, August 3 through Tuesday August 18, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare |
| 2026-07-15 |
Auna Reports Preliminary Key Performance Indicators for the Second Quarter ended June 30, 2026
Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Second Quarter ended June 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance Indicators As of second quarter ended June 30, 2026 Healthcare Services Mexico Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # 8,170 7,274 8,002 7,864 7,892 Surgeries (2) # 4,904 5,177 5,028 4,855 5,193 Total number of days hospitalized (3) # 24,791 25,450 24,156 25,122 25,169 Total Capacity Utilization (4) % 38.5% 39.1% 37.1% 39.4% 39.1% Chemotherapies & Radiotherapies (sessions) (5) # 2,690 3,678 3,983 4,162 4,994 Healthcare Services Peru Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments (1) # |
| 2026-05-19 |
Auna Announces 1Q26 Financial Results
Strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by revenue adjustments; Mexico volumes and revenues growing rapidly, with Segment Adjusted EBITDA increasing 19% QoQ Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 1Q’26 Consolidated Highlights Revenue increased 10% FXN, or 13% YoY on a reported basis, to S/1,178 million Mexico Revenue increased 15% YoY on a reported basis, to S/ 279 million Adjusted EBITDA was S/217 million, a decrease of 2% YoY Adjusted EBITDA Margin of 18.4%, down 2.9 p.p. YoY from 21.4% in 1Q25 Operating Cash Flow and Free Cash Flow |
| 2026-04-22 |
Auna Announces the Filing of Its Form 20 F for the Fiscal Year 2025
Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA) , a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission (the “SEC”) on April, 21, 2026. Auna’s Annual Report on Form 20-F can be accessed by visiting either the SEC’s website at www.sec.gov or the “Financial Info” section of the Company’s Investor Relations website at www.aunainvestors.com . In addition, shareholders may receive a hard copy of the Company’s audited financial statements, or its complete 2025 Form 20-F including audited financial statements, free of charge, by requesting a copy from the Investor Relations team at [email protected] About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest |
| 2026-04-17 |
Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026
Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance Indicators As of first quarter ended March 31, 2026 Healthcare Services Mexico Key Operating Metrics 1Q'25 2Q'25 3Q'25 4Q'25 1Q'26 Emergency treatments (1) # (000) 8,053 8,170 7,274 8,002 7,864 Surgeries (2) # (000) 4,687 4,904 5,177 5,028 4,855 Total number of days hospitalized (3) # 25,344 24,791 25,450 24,156 25,122 Total Capacity Utilization (4) % 39.8% 38.5% 39.1% 37.1% 39.4% Chemotherapies & Radiotherapies (sessions) (5) # 2,333 < |
| 2026-04-15 |
Auna Announces Reporting Dates for First Quarter 2026 Financial Results
Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Tuesday, May 19, 2026 Time: After Market Close Conference Call Wednesday, May 20, 2026 Time: 8:00 a.m. ET Quiet Period Monday, May 4 through Tuesday May 19, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms |
| 2026-03-10 |
Auna Announces 4Q25 and FY25 Financial Results
Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Growth Guidance for 2026 Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 (“fourth quarter 2025” or “4Q25”) and full-year ended 2025 (“full-year 2025” or “FY25”). Financial results are expressed in Peruvian Soles (“S/” or “PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. FY25 Consolidated Highlights Revenue increased 4% FXN to S/4,385 million, and was flat on reported basis Adjusted EBITDA decreased 3% FXN, or 8% YoY on reported basis, to S/917 million Adjusted EBITDA Margin of 20.9%, down 1.7 p.p. YoY from 22.6% in FY24 Operating Cash Flow and Free Cash Flow |
| 2026-02-26 |
Auna and EsSalud Finalize Addendum to Commence Construction of Torre Trecca in Lima, Which Will Become Peru’s Largest Outpatient Facility
Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today announced the formal execution of an addendum to its existing Public-Private Partnership (“PPP”) agreement with EsSalud, Peru’s Social Health Insurance agency. This agreement facilitates the commencement of the construction phase of the Torre Trecca project in Lima. The execution of the addendum is an important milestone for the project and formally authorizes the commencement of construction of Torre Trecca, a 23-story, high-complexity outpatient healthcare facility. The facility will encompass approximately 59,000 square meters of built area, 145 consultation offices, and 43 treatment rooms. Upon its completion, Torre Trecca is expected to expand EsSalud’s healthcare capacity in metropolitan Lima by approximately 20%. Furthermore, it will substantially reduce waiting times for more than six million insured Peruvians, with the capacity to |
| 2026-02-02 |
Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2025 Financial Results
Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest |
| 2025-11-20 |
Auna Announces 3Q25 Financial Results
Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”) , a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 (“third quarter 2025” or “3Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjusted EBITDA decreased 5% FXN, or 7% YoY on reported basis, to S/232 million Adjusted EBITDA Margin of 20.8%, down 1.3 p.p. YoY from 22.1% Adjusted Net Income was S/58 million, down from S/75 million in 3Q24 Leverage Ratio remains unchanged at 3.6x Mexico’s surgeries and oncology services increased for the second consecutive quarter Oncology MLR decreased to 49.3% Message from Auna’s Executive Chairman and President Despite weaker financial yet promising operational results, the third quarter of 2025 demonstrates the enduring resilience of Auna’s integrated regional healthcare platform and the robust performance of our operations. The operations in Peru and Colombia achieved substantial growth and profitability in local currency, despite challenging macroeconomic conditions, while in our Mexico business, which is slowly recovering from previously communicated challenges, hospital operations remained stable, although the segment delivered less favorable financial results. In Peru, both Oncosalud and Healthcare Services delivered consistently strong performance levels, supported by growth in memberships, annual pricing adjustments, and the sustained improvement of the Oncology MLR to 49.3%. The disciplined containment of costs and the operational efficiency of our medical talent continued to underpin this performance. Our results were strong in Colombia, with double-digit growth in Adjusted EBITDA and continued expansion of risk-sharing Prospective Global Payment (“PGP”) models. The team's focus on reducing exposure to intervened payors and optimizing resource utilization supported profitability and improved cash generation. In Mexico, despite a second consecutive quarterly increase in the number of surgeries and growth in oncology and cardiology services, revenues and profitability declined year over year due to still lackluster demand for medical procedures, a sluggish recovery of volumes affected by legacy physician and supplier relationships, and migration issues related to the implementation of new Hospital Information and ERP systems at Doctors Hospital, which we expect to resolve in the coming months. At the consolidated level, our leverage remained stable at 3.6x Net Debt-to-Adjusted EBITDA, reflecting a disciplined approach to capital allocation, a robust cash position, and continued progress toward our medium-term deleveraging objective of below 3x. Additionally, following quarter-end, Auna completed a USD765 million debt refinancing that extends debt maturities, reduces interest costs, and further fortifies Auna’s capital structure. Complementing these efforts, the announcement of our partnership with Sojitz and the recent Trecca milestone underscore the confidence in our strategy in Mexico and the significant opportunities that remain in Peru, while a |
| 2025-11-20 |
Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America
LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America (“Sojitz”), a global investment and trading group headquartered in Japan, have entered into a Memorandum of Understanding (MOU) to explore joint business opportunities in the healthcare sector across Latin America, with an initial focus on Mexico, one of the region’s largest and fastest-growing healthcare markets. On September 24, 2025, Auna announced its intention to invest approximately US$500 million over the next three to five years to expand its integrated healthcare platform in Mexico. The collaboration seeks to combine Auna’s healthcare and operational expertise with Sojitz’s investment capabilities in healthcare and international network to accelerate the development of modern, scalable, and accessible healthcare infrastructure and services in Latin America. “We have had ongoing conversations with Sojitz over the years about joining forces, and this framework cements our shared vision. This agreement marks an important step in Auna’s strategy to expand our integrated care model and bring high-quality healthcare to more people in Mexico and across Latin America,” said Suso Zamora, Executive Chairman and President of Auna. “We are very pleased to collaborate with Auna, whose mission to expand access to high quality healthcare aligns closely with Sojitz’s commitment to building sustainable businesses that create long-term social value,” said Koichi Yamaguchi, President of Sojitz Corporation of America. About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of June 30, 2025, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members. Cautionary Statement on Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about the Company’s collaboration with Sojitz and planned investments in Mexico. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna’s filings with the United States Securities and Exchange |
| 2025-11-18 |
Construction License for Torre Trecca Is Granted to EsSalud, Marking Key Milestone in Auna’s Public–Private Partnership with the Institution
LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru’s Social Security System, has formally received the construction license for Torre Trecca, a high-rise outpatient treatment center that Auna will rebuild and, upon completion, operate on behalf of EsSalud as part of an existing public–private partnership (“PPP”). When completed, Torre Trecca is expected to serve more than six million Peruvians living in the city of Lima who are insured by EsSalud and to accommodate more than three million visits annually. The license milestone was commemorated during a ceremony attended by the Executive Director of ProInversión (the Peruvian government agency that promotes private investment), Luis Del Carpio; the Executive President of EsSalud, Segundo Acho Mego; the Mayor of the Jesús María District, Jesús Gálvez, and the Vice Chairman of Auna, Luis Felipe Pinillos. Auna first entered into the PPP with EsSalud in 2010 to rebuild Torre Trecca and operate the facility on behalf of the institution. The approval and formal delivery of the construction license to EsSalud represents an important step toward upgrading and modernizing this high-impact healthcare project. The amendment to the Torre Trecca PPP contract awarded to Auna is expected to receive final approval by the end of this year, enabling construction to begin in 2026. Auna reaffirmed its commitment to expanding access to high-quality healthcare services for the people of Lima. This significant milestone in the advancement of the PPP underscores the substantial progress achieved through the close collaboration of EsSalud and ProInversión. About Auna Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of June 30, 2025, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members. Cautionary Statement on Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about the expected final approval and beginning of construction of Torre Trecca in 2026 and the expected capacity and market of Torre Trecca once built. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to mate |
Past events
Source: https://www.aunainvestors.com/